Top

Published in:

Open Access 01-12-2010 | Review

Cellular receptor binding and entry of human papillomavirus

Authors: Tan Letian, Zhang Tianyu

Published in: Virology Journal | Issue 1/2010

Abstract

Human papillomaviruses (HPVs), recognized as the etiological agents for the skin, plantar, genital, and laryngopharyngeal wart, have been previously in numerous studies demonstrated to present a close link between HPV infection and certain human cancers, some putative candidates of HPV cell receptor and possible pathways of cell entry proposed. This review was to highlight the investigations and remaining questions regarding the binding and entry process.

Roden RB, Kirnbauer R, Jenson AB, Lowy DR, Schiller JT: Interaction of papillomaviruses with the cell surface. J Virol 1994, 68: 7260-7266.PubMedPubMedCentral

Evander M, Frazer IH, Payne E, Qi YM, Hengst K, McMillan NA: Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol 1997, 71: 2449-2456.PubMedPubMedCentral

Patterson NA, Smith JL, Ozbun MA: Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate. J Virol 2005, 79: 6838-6847. 10.1128/JVI.79.11.6838-6847.2005PubMedPubMedCentralCrossRef

Conway MJ, Meyers C: Replication and assembly of humanpapillomaviruses. J Dent Res 2009, 88: 307-317. 10.1177/0022034509333446PubMedPubMedCentralCrossRef

Wang HK, Duffy AA, Broker TR, Chow LT: Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev 2009, 23: 181-194. 10.1101/gad.1735109PubMedPubMedCentralCrossRef

Chow LT, Duffy AA, Wang HK, Broker TR: A highly efficient system to produce infectious human papillomavirus: Elucidation of natural virus-host interactions. Cell Cycle 2009, 8: 1319-1323.PubMedCrossRef

Muller M, Gissmann L, Cristiano RJ, Sun XY, Frazer IH, Jenson AB, Alonso A, Zentgraf H, Zhou J: Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol 1995, 69: 948-954.PubMedPubMedCentral

Volpers C, Unckell F, Schirmacher P, Streeck RE, Sapp M: Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J Virol 1995, 69: 3258-3264.PubMedPubMedCentral

Qi YM, Peng SW, Hengst K, Evander M, Park DS, Zhou J, Frazer IH: Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein. Virology 1996, 216: 35-45. 10.1006/viro.1996.0032PubMedCrossRef

10.

McMillan NA, Payne E, Frazer IH, Evander M: Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology 1999, 261: 271-279. 10.1006/viro.1999.9825PubMedCrossRef

11.

Yoon CS, Kim KD, Park SN, Cheong SW: alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Biochem Biophys Res Commun 2001, 283: 668-673. 10.1006/bbrc.2001.4838PubMedCrossRef

12.

Giancotti FG, Stepp MA, Suzuki S, Engvall E, Ruoslahti E: Proteolytic processing of endogenous and recombinant beta 4 integrin subunit. J Cell Biol 1992, 118: 951-959. 10.1083/jcb.118.4.951PubMedCrossRef

13.

Kajiji S, Tamura RN, Quaranta V: A novel integrin (alpha E beta 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. EMBO J 1989, 8: 673-680.PubMedPubMedCentral

14.

Kurpakus MA, Quaranta V, Jones JC: Surface relocation of alpha 6 beta 4 integrins and assembly of hemidesmosomes in an in vitro model of wound healing. J Cell Biol 1991, 115: 1737-1750. 10.1083/jcb.115.6.1737PubMedCrossRef

15.

Bretscher MS: Cells can use their transferrin receptors for locomotion. EMBO J 1992, 11: 383-389.PubMedPubMedCentral

16.

Sonnenberg A, Calafat J, Janssen H, Daams H, Raaij-Helmer LM, Falcioni R, Kennel SJ, Aplin JD, Baker J, Loizidou M, Garrod D: Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol 1991, 113: 907-917. 10.1083/jcb.113.4.907PubMedCrossRef

17.

Selinka HC, Giroglou T, Nowak T, Christensen ND, Sapp M: Further evidence that papillomavirus capsids exist in two distinct conformations. J Virol 2003, 77: 12961-12967. 10.1128/JVI.77.24.12961-12967.2003PubMedPubMedCentralCrossRef

18.

Knappe M, Bodevin S, Selinka HC, Spillmann D, Streeck RE, Chen XS, Lindahl U, Sapp M: Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate. J Biol Chem 2007, 282: 27913-27922. 10.1074/jbc.M705127200PubMedCrossRef

19.

Joyce JG, Tung JS, Przysiecki CT, Cook JC, Lehman ED, Sands JA, Jansen KU, Keller PM: The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem 1999, 274: 5810-5822. 10.1074/jbc.274.9.5810PubMedCrossRef

20.

Giroglou T, Florin L, Schafer F, Streeck RE, Sapp M: Human papillomavirus infection requires cell surface heparan sulfate. J Virol 2001, 75: 1565-1570. 10.1128/JVI.75.3.1565-1570.2001PubMedPubMedCentralCrossRef

21.

Combita AL, Touze A, Bousarghin L, Sizaret PY, Munoz N, Coursaget P: Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate. FEMS Microbiol Lett 2001, 204: 183-188. 10.1111/j.1574-6968.2001.tb10883.xPubMedCrossRef

22.

Selinka HC, Giroglou T, Sapp M: Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology 2002, 299: 279-287. 10.1006/viro.2001.1493PubMedCrossRef

23.

Shafti-Keramat S, Handisurya A, Kriehuber E, Meneguzzi G, Slupetzky K, Kirnbauer R: Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol 2003, 77: 13125-13135. 10.1128/JVI.77.24.13125-13135.2003PubMedPubMedCentralCrossRef

24.

Rommel O, Dillner J, Fligge C, Bergsdorf C, Wang X, Selinka HC, Sapp M: Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: basis for a virus-like particle ELISA. J Med Virol 2005, 75: 114-121. 10.1002/jmv.20245PubMedCrossRef

25.

Chen XS, Garcea RL, Goldberg I, Casini G, Harrison SC: Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell 2000, 5: 557-567. 10.1016/S1097-2765(00)80449-9PubMedCrossRef

26.

Modis Y, Trus BL, Harrison SC: Atomic model of the papillomavirus capsid. EMBO J 2002, 21: 4754-4762. 10.1093/emboj/cdf494PubMedPubMedCentralCrossRef

27.

Day PM, Thompson CD, Buck CB, Pang YY, Lowy DR, Schiller JT: Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol 2007, 81: 8784-8792. 10.1128/JVI.00552-07PubMedPubMedCentralCrossRef

28.

Carter JJ, Wipf GC, Benki SF, Christensen ND, Galloway DA: Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1. J Virol 2003, 77: 11625-11632. 10.1128/JVI.77.21.11625-11632.2003PubMedPubMedCentralCrossRef

29.

Sibbet G, Romero-Graillet C, Meneguzzi G, Campo MS: alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4. J Gen Virol 2000, 81: 327-334.PubMedCrossRef

30.

Johnson KM, Kines RC, Roberts JN, Lowy DR, Schiller JT, Day PM: Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol 2009, 83: 2067-2074. 10.1128/JVI.02190-08PubMedPubMedCentralCrossRef

31.

Mudhakir D, Harashima H: Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus. AAPS J 2009, 11: 65-77. 10.1208/s12248-009-9080-9PubMedPubMedCentralCrossRef

32.

Sieczkarski SB, Whittaker GR: Dissecting virus entry via endocytosis. J Gen Virol 2002, 83: 1535-1545.PubMedCrossRef

33.

Day PM, Lowy DR, Schiller JT: Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 2003, 307: 1-11. 10.1016/S0042-6822(02)00143-5PubMedCrossRef

34.

Bousarghin L, Touze A, Sizaret PY, Coursaget P: Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J Virol 2003, 77: 3846-3850. 10.1128/JVI.77.6.3846-3850.2003PubMedPubMedCentralCrossRef

35.

Hindmarsh PL, Laimins LA: Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry. Virol J 2007, 4: 19. 10.1186/1743-422X-4-19PubMedPubMedCentralCrossRef

36.

Smith JL, Campos SK, Ozbun MA: Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes. J Virol 2007, 81: 9922-9931. Laniosz V, Holthusen KA, Meneses PI: Bovine papillomavirus type 1: from clathrin to caveolin. J Virol 2008, 82:6288-6298. 10.1128/JVI.00988-07PubMedPubMedCentralCrossRef

37.

Smith JL, Campos SK, Wandinger-Ness A, Ozbun MA: Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating. J Virol 2008, 82: 9505-9512. 10.1128/JVI.01014-08PubMedPubMedCentralCrossRef

38.

Laniosz V, Holthusen KA, Meneses PI: Bovine papillomavirus type 1: from clathrin to caveolin. J Virol 2008, 82: 6288-6298. 10.1128/JVI.00569-08PubMedPubMedCentralCrossRef

39.

Abban CY, Bradbury NA, Meneses PI: HPV16 and BPV1 infection can be blocked by the dynamin inhibitor dynasore. Am J Ther 2008, 15: 304-311. 10.1097/MJT.0b013e3181754134PubMedPubMedCentralCrossRef

40.

Spoden G, Freitag K, Husmann M, Boller K, Sapp M, Lambert C, Florin L: Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs). PLoS One 2008, 3: e3313. 10.1371/journal.pone.0003313PubMedPubMedCentralCrossRef

41.

Hemler ME: Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol 2003, 19: 397-422. 10.1146/annurev.cellbio.19.111301.153609PubMedCrossRef

42.

Levy S, Shoham T: Protein-protein interactions in the tetraspanin web. Physiology (Bethesda) 2005, 20: 218-224.CrossRef

43.

Day PM, Lowy DR, Schiller JT: Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids. J Virol 2008, 82: 12565-12568. 10.1128/JVI.01631-08PubMedPubMedCentralCrossRef

44.

Richards RM, Lowy DR, Schiller JT, Day PM: Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci USA 2006, 103: 1522-1527. 10.1073/pnas.0508815103PubMedPubMedCentralCrossRef

45.

Kamper N, Day PM, Nowak T, Selinka HC, Florin L, Bolscher J, Hilbig L, Schiller JT, Sapp M: A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol 2006, 80: 759-768. 10.1128/JVI.80.2.759-768.2006PubMedPubMedCentralCrossRef

Title: Cellular receptor binding and entry of human papillomavirus
Authors: Tan Letian
Zhang Tianyu
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI: https://doi.org/10.1186/1743-422X-7-2

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Cellular receptor binding and entry of human papillomavirus

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Viral replication is enhanced by an HIV-1 intersubtype recombination-derived Vpu protein

Co-receptor usage and prediction of v3 genotyping algorithms in hiv-1 subtype b' from paid blood donors experienced anti-retroviral therapy in chinese central province

Development and validation of an ELISA using a protein encoded by ORF2 antigenic domain of porcine circovirus type 2

Molecular characterization of Chikungunya virus isolates from clinical samples and adult Aedes albopictus mosquitoes emerged from larvae from Kerala, South India

Post-transcriptional control by bacteriophage T4: mRNA decay and inhibition of translation initiation

Chicken cyclophilin A is an inhibitory factor to influenza virus replication

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page